Industry News

Pharmaceutical Industry News

The CDC’s recommendation for…

September 19th, 2025|Fierce Pharma|

The CDC's recommendation for Gilead's twice-yearly Yeztugo as an HIV PrEP option was hailed by HIV advocacy groups but stirred up pressure for CVS Health to include the drug on its formularies.

Europe’s Committee for Medicinal…

September 19th, 2025|Fierce Pharma|

Europe's Committee for Medicinal Products for Human Use (CHMP) has recommended several drugs for approval, including Novo Nordisk's once-weekly diabetes drug Kyinsu and Bayer's menopause treatment Lynkuet.

Freda Lewis-Hall, M.D., former…

September 19th, 2025|Fierce Pharma|

Freda Lewis-Hall, M.D., former Pfizer chief medical officer, joins "The Top Line" to discuss rebuilding patient trust, listening before messaging and what it means to put a human face on pharma.

The lawsuits were part of the…

September 19th, 2025|Fierce Pharma|

The lawsuits were part of the large web of COVID-19 vaccine patent infringement cases filed against—and by—the most prominent vaccine makers.

In a perplexing conclusion to an…

September 18th, 2025|Fierce Pharma|

In a perplexing conclusion to an oftentimes tense meeting of the CDC’s Advisory Committee on Immunization Practices Thursday, the panelists—assembled recently in the aftermath of Robert F. Kennedy Jr.’s purge of the committee—seemed to contradict

Perhaps the best way to think of…

September 18th, 2025|Fierce Pharma|

Perhaps the best way to think of today’s pharma marketing landscape is as a one-way street. Information flows to healthcare professionals (HCPs) through carefully crafted communications, including emails and SMS messages, but physicians often lack

BMS is exiting the first…

September 18th, 2025|Fierce Pharma|

BMS is exiting the first U.S.-China pharmaceutical joint venture. Two biotechs have launched with backing from big venture capital firms and Chinese assets. Roche and Johnson & Johnson are reportedly eyeing an antibody-drug conjugate deal

In addition to manufacturing drug…

September 18th, 2025|Fierce Pharma|

In addition to manufacturing drug substance for argenx’s autoimmune blockbuster Vyvgart at its facility in Hillerød, Denmark, Fujifilm will also make the product at its large-scale complex in Holly Springs, N.C., starting in 2028.

Nearly three years after…

September 18th, 2025|Fierce Pharma|

Nearly three years after originating the role, Erica Taylor, Ph.D., is stepping down as chief marketing officer of Genentech.

Over the last six years, three…

September 18th, 2025|Fierce Pharma|

Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with type 2 diabetes. Now this rapidly growing patient population is a step closer to gaining access to

The duel of the GLP-1 data sets…

September 18th, 2025|Fierce Pharma|

The duel of the GLP-1 data sets continues this week, with Novo issuing the latest salvo of updates on its oral obesity candidate and an Ozempic head-to-head trial win against another stalwart diabetes treatment. In

MilliporeSigma, a unit of…

September 18th, 2025|Fierce Pharma|

MilliporeSigma, a unit of Germany's Merck KGaA, opened a €150 million ($177 million) filtration products plant in Cork, bolstering the company’s goal to expand global manufacturing operations.

Insulet is bringing a splash of…

September 18th, 2025|Fierce Pharma|

Insulet is bringing a splash of color to the diabetes technology market. Working with Pantone, the insulin pump company has created the “bright and joyful tropical orange yellow” color Omnipod Mango.

Merck is stepping up to the plate…

September 17th, 2025|Fierce Pharma|

Merck is stepping up to the plate to raise awareness of the dangers of high LDL cholesterol and how it can increase the risk of atherosclerotic cardiovascular disease (ASCVD).

Former CDC Director Susan Monarez,…

September 17th, 2025|Fierce Pharma|

Former CDC Director Susan Monarez, Ph.D., told senators the health secretary claimed there was "no science or evidence" supporting the current childhood vaccine schedule and that he had the president's backing to impose changes without

Novo Nordisk is not wasting time…

September 17th, 2025|Fierce Pharma|

Novo Nordisk is not wasting time beginning the layoffs it announced last week as it is dismissing 263 employees from its U.S. headquarters in Plainsboro, New Jersey. Additionally, Bristol Myers Squibb is cutting 282 workers

As patients and healthcare…

September 17th, 2025|Fierce Pharma|

As patients and healthcare professionals alike increasingly turn to artificial intelligence tools like OpenAI’s ChatGPT and Google’s Gemini rather than traditional search engines for online research, pharma marketers will need to significantly shift their strategies